M R Jacobs - Concepedia

Author

M R Jacobs

Case Western Reserve University

Also Known As

M Jacobs, M R Jacobs, M. R. JACOBS, M. R. Jacobs, M.R. Jacobs, MICHAEL R. JACOBS, Michael R. Jacobs, Michael R. Jacobs

Publications

Citations

H-Index

Concepts

All Affiliations

Case Western Reserve University University Hospitals of Cleveland University of the Witwatersrand South African Institute for Medical Research Centers for Disease Control and Prevention

About

M R Jacobs is an author at Case Western Reserve University specializing in medicine, clinical microbiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	902
2	Microbiology	17	18	892
3	Health Sciences	15	17	807
4	Epidemiology	2	2	60
5	Engineering	1	1	76

M R Jacobs

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group Scott F. Dowell, Jay C. Butler, G. Scott Giebink, The Pediatric Infectious Disease Journal	1999	508
Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media Ron Dagan, CANDICE E. JOHNSON, Samuel E. McLinn, The Pediatric Infectious Disease Journal	2000	177
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin S C Aronoff, M R Jacobs, S Johenning, Antimicrobial Agents and Chemotherapy PharmacotherapyAntimicrobial ChemotherapyAntibiotic ResistanceDrug ResistanceSodium Clavulanate	1984	123
Pneumococcal Conjugate Vaccine Serotypes of<i>Streptococcus pneumoniae</i>Isolates and the Antimicrobial Susceptibility of Such Isolates in Children with Otitis Media Moses Joloba, Anne Windau, Saralee Bajaksouzian, Clinical Infectious Diseases	2001	104
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli M R Jacobs, S C Aronoff, S Johenning, Antimicrobial Agents and Chemotherapy Beta-lactamase InhibitorsYtr 830Antimicrobial SusceptibilityHealth SciencesAntibiotics	1986	95
Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes Peter C. Appelbaum, M R Jacobs, S K Spangler, Antimicrobial Agents and Chemotherapy Beta-lactamase InhibitorsBeta-lactamase-producing AnaerobesComparative ActivityAntimicrobial SusceptibilityHealth Sciences	1986	84
Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs Siok Siong Ching, H Lee, Edward W. Hook, Journal of Clinical Microbiology Ligase Chain ReactionEngineeringCervical CancerPathogen DetectionMedicine	1995	76
Anti-Mycobacterium avium activity of quinolones: in vitro activities Gilles Klopman, Shaomeng Wang, M R Jacobs, Antimicrobial Agents and Chemotherapy Active PortionsAntimicrobial SusceptibilityHealth SciencesAntibioticsMedicine	1993	57
Topical fluoroquinolones: Antimicrobial activity and<i>in vitro</i>corneal epithelial toxicity Paul E. Cutarelli, Jonathan H. Lass, Hillard M. Lazarus, Current Eye Research	1991	54
Infection caused by vancomycin-resistant Streptococcus sanguis II David M. Shlaes, Jennifer L. Marino, M R Jacobs Antimicrobial Agents and Chemotherapy Gram-positive IsolatesAntimicrobial SusceptibilityHealth SciencesAntibioticsRare Occurrence	1984	51

Page 1